Cargando…
Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
BACKGROUND AND AIM: The United Kingdom‐primary biliary cholangitis (UK‐PBC) and global primary biliary cholangitis group (GLOBE) prognostic models have been recently developed to predict long‐term outcomes in primary biliary cholangitis (PBC). However, these predictive scores have not yet been well...
Autores principales: | Alomari, Mohammad, Covut, Fahrettin, Al Momani, Laith, Chadalavada, Pravallika, Hitawala, Asif, Young, Mark F, Romero‐Marrero, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144790/ https://www.ncbi.nlm.nih.gov/pubmed/32280755 http://dx.doi.org/10.1002/jgh3.12223 |
Ejemplares similares
-
External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018) -
Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021) -
Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)